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CORRESPONDENCE
Letters to the Editor
Accuracy of Noninvasive Coronary
Angiography Using Computed Tomography
As the excellent work presented by Raff et al. (1) on the diagnostic
accuracy of 64-slice computed tomography for assessing coronary
artery disease is of great interest to a large readership, I would like
to bring to your attention an error in the Abstract. The terms
“specificity” and “sensitivity” seem to have been mixed up in the
Abstract, as can be confirmed by comparing the results in the
Abstract with the numbers given in the text and in Table 2. This
“explains” the rather low value in the Abstract for sensitivity in the
per segment analysis.
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We thank Dr. Kaufmann for pointing out a typographical error in the
Abstract of our study, in which the terms sensitivity and specificity were
reversed (1). The corrected sentence should read: “Sensitivity, speci-
ficity, and positive and negative predictive values for the presence of
significant stenoses were, by segment (n  935), 86%, 95%, 66%,
98%; by artery (n 279), 91%, 92%, 80%, 97%; by patient (n 70),
95%, 90%, 93%, 93%.” These values were correctly represented in the
body of the report.
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Mesenchymal Stem Cells
Repair Conduction Block
In a recent study, Beeres et al. (1) addressed the potency of human
adult bone marrow mesenchymal stem cells (MSCs) to connect
separated sheets of cultured cardiomyocytes electrically. Thereby
they touch upon a delicate and important feature with respect to
cardiac regeneration by means of cell therapy (i.e., functional
coupling and action potential propagation).
In the last years numerous studies have been performed to
investigate applicability of stem cells or stem-cell–derived cardio-
myocytes in cardiac regeneration strategies. In vitro studies re-
vealed that several sources of stem cells could be differentiated with
varying levels of success into cardiomyocytes. In general, the
phenotype of most sources of stem-cell–derived cardiomyocytes
appears rather immature. In contrast to host ventricular myocar-
dium, these cells display spontaneous electrical activity, thereby
baring the seeds of creating an ectopic focus upon transplantation.
To optimally support a compromised myocardium upon engraft-
ment, donor cells preferably should be as similar as—and integrate
mechanically and electrically with—the receiving host myocar-
dium. If not, transplantation of cells will not only fail to chronically
increase the contractile capacity of the heart but, even more
deleterious, will disturb impulse formation and propagation. This
risk was acknowledged in a study by Menasche et al. (2), who
showed the onset of lethal ventricular tachyarrhythmias upon
transplantation of the recipient’s own myoblasts. The fact that
these cells do not, or hardly express gap junctions and thereby
create a large excitable gap to the host myocardium—together with
their potency to display aberrant electrical activity—probably
explains the observed arrhythmias. Abraham et al. (3) showed that
a genetically increased level of gap junctions tempered this arrhyth-
mogenic behavior in vitro.
In the study by Beeres et al. (1), the investigators confirm the
requirement of sufficient coupling between host and donor cells
because fibroblasts and skeletal myoblasts were unable to restore
impulse propagation, whereas MSCs expressing gap junctions did.
However, the impulse was propagated passively over rather short
distances, and because the cells are not excitable, they will be
unable to carry the action potential over larger distances. More-
over, upon transplantation, it is unlikely that they will support the
contractility by lack of a well-developed functional contractile
apparatus (4). As mentioned by Beeres et al. (1), these engrafted
cells do not trigger the onset of arrhythmias, which in our opinion
relates to this inexcitable characteristic of these functionally cou-
pled cells. We believe that if donor cardiomyocytes are desired to
engraft in order to support the contractile capacity, the combina-
tion of functional electrical coupling and spontaneous activity has
to be ruled out by eliminating the latter. As shown by Kehat et al.
(5), transplantation of clustered human embryonic stem cells that
express gap junctions and are spontaneously active enables ectopic
pacemaking (5).
To engraft cells safely in the compromised heart in order to
support it mechanically, intercellular coupling to host cells has to
be optimized while spontaneous activity should be depressed. With
the results from the study by Beeres and the other studies cited,
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scientists are challenged to develop such strategies in which the
aspect of electrical interaction is included and controlled.
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We thank Dr. van Veen and colleagues for emphasizing the
importance of optimal electrical coupling between cells trans-
planted into ischemically damaged myocardium and host cardio-
myocytes. We fully agree that electrical integration of transplanted
cells into the acceptor myocardium is essential to: 1) prevent
occurrence of life-threatening arrhythmias; and 2) enhance the
contractile capacity through coordinated contraction of host car-
diomyocytes and transplanted cells.
Our recent in vitro model study, aimed at investigating the
electrophysiological properties of human mesenchymal stem cells
(MSCs), demonstrated connexin-mediated conduction of the ac-
tion potential across MSCs (1). In our opinion, the observed
impulse transmission (although mainly passive within the first 24
to 48 h) may be sufficient to prevent the occurrence of pro-
arrhythmogenic large excitable gaps in transplanted areas. This is
corroborated by the finding that at present no increased inducibility of
arrhythmias was reported after transplantation of autologous bone-
marrow–derived cells in patients with ischemic heart disease (2). In
particular, repetitive electrocardiographic monitoring after MSC
transplantation for acute myocardial infarction did not reveal
increased occurrence of arrhythmias (3). Long-term in vitro
recordings should elucidate whether conduction velocity, ampli-
tude, and depolarization rate of the MSC electrograms increase
48 h after MSC application.
van Veen and colleagues suggest that transplantation of MSCs
may not support the contractile capacity as MSCs injected in a rat
myocardial infarction model lacked a well-developed functional
contractile apparatus (4). However, a number of clinical studies
have reported on improved left ventricular ejection fraction after
bone marrow cell transplantation (2,3). Furthermore, it should be
emphasized that the mechanism by which bone-marrow–cell
transplantation improves cardiac function remains uncertain. The
MSC-induced improvement in left ventricular ejection fraction
described by Chen et al. (3) may either result from 1) differenti-
ation of MSCs into cardiomyocytes (which inherently support
myocardial contractility) or from 2) paracrine signaling by trans-
planted MSCs (which humorally stimulate the function of resident
or recruited cardiac [progenitor] cells) (5). Clearly, additional
research is warranted to provide more insight into the mechanism
of the contractile improvement after bone-marrow–cell transplan-
tation.
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The Other Face of the Medal:
The Risks of Exercise Training
I read with interest the recent study in the Journal by Noda et al.
(1) who concluded that exercise training might reduce the risk of
mortality from coronary heart disease and stroke in Asian popu-
lations. However, several limitations of the study need to be
considered. Indeed, except for walking, both intensive and pro-
longed exercises may have harmful effects on the cardiovascular
system regardless of the time spent participating in sporting
activities. In particular, acute heavy exercise may cause myocardial
ischemia, myocardial infarction, and cardiovascular stroke because
of suddenly increasing blood pressure, uncontrolled heart rate, and
oxygen demand (2). Noda et al. (1) should perhaps clarify the role
of intense physical activity in postponing mortality in the cardiac
patient.
Although there is strong epidemiological evidence that a dose-
response relationship exists between physical activity and all-cause
mortality, there is a consistent inverse dose-response relationship
between physical activity and both the incidence and mortality
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